Earnix Appoints Craig Campestre as Chief Revenue Officer to Drive Strategic Growth
BOSTON–(BUSINESS WIRE)–Earnix, the leading global provider of AI-based SaaS solutions for financial services, today announced the appointment of Craig... Read more.
SafeSport Implementing Improvements to Increase Efficiency and Information Sharing
Eight-month review, stakeholder engagement results in significant process changes DENVER–(BUSINESS WIRE)–The U.S. Center for SafeSport (the Center) today... Read more.
Pembina Pipeline Corporation Announces Closing of Acquisition of Enbridge’s Interest in Alliance/Aux Sable and Raises 2024 Guidance
CALGARY, Alberta–(BUSINESS WIRE)–Pembina Pipeline Corporation (“Pembina” or the “Company”) (TSX: PPL; NYSE: PBA) is pleased to... Read more.
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement
Collaboration combines Teva’s expertise in respiratory technology development and Launch Therapeutics’ innovative late-stage drug development model to progress... Read more.
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
Povorcitinib, a selective oral JAK1 inhibitor discovered by Incyte, is an investigational medicine being evaluated for the treatment of non-segmental vitiligo, hidradenitis... Read more.
Amprius Sets April 2024 Events Schedule
FREMONT, Calif.–(BUSINESS WIRE)–Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion... Read more.
IDC Estimates that GenAI Will Increase Marketing Productivity More Than 40% by 2029
NEEDHAM, Mass.–(BUSINESS WIRE)–#AIMarketing–New research from International Data Corporation (IDC) shows that applying generative artificial intelligence... Read more.
Align Technology to Announce First Quarter 2024 Results on April 24, 2024
TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the... Read more.
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
Key study underway in registration-directed PALISADE Phase 3 program for fasedienol in social anxiety disorder Social anxiety disorder affects over 25 million Americans... Read more.
Guerrilla RF Announces Completion of $5.0 Million Private Placement Equity Financing and Related Transactions
Company completes private placement equity financing and debt conversion; total transaction value of $5.0 million Company extends maturity of $12 million debt facility... Read more.